Investor Relations

Investor Relations

Hospira is now a subsidiary of Pfizer Inc.

For shareholder questions, please click here
Pfizer Completes Acquisition of Hospira


Hospira, Inc. is now a subsidiary of Pfizer Inc. Hospira is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. It is the only North American company to offer biosimilars on market in Europe and Australia. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 19,000 employees worldwide and generated approximately $4.5 billion in net sales in 2014. Learn more >

Investor Presentations

Investor Presentations

Annual Report

2014 Annual Report

Recent News

09/03/15Pfizer Completes Acquisition of Hospira Printer Friendly Version
08/27/15Hospira Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™Printer Friendly Version
08/25/15Hospira and Cerner Expand Agreement to Advance Integration of I.V.-EMR TechnologyPrinter Friendly Version

Tax Information for Shareholders

Tax/Cost Basis InformationDownload Documentation 
U.S. Tax Reporting StatementDownload Documentation 
Canadian Tax Reporting StatementDownload Documentation 

Hospira Code of Business Conduct